This company is completely gone, and it's very sad.
They are sub scale, and don't have the capital to roll out anywhere near enough clinics to get the scale required.
They are saddled with far to much legacy corporate overhead from the old business, which will be difficult to shed.
Not to mention the macro headwinds..
It's still an epic short for me..
The one risk to the short thesis, is that perversely, the bits are worth more than the sum at this point..
They could (and should) sell everything off. A reasonable sale price plus cash on hand equals more than market cap.. But every month they keep it, the cash goes down, and they get ever more trapped...
